Abstract: A novel cell line for use as a parent for hybridoma preparation is provided. This cell line is derived from tumor cells, in particular human tumor cells, other than those originating from bone marrow cells. A method for establishing this cell line is also provided. By fusing this cell line with cells producing useful physiologically active substances, such as B cells immunized with an antigen, a hybridoma capable of active growth can be prepared. This hybridoma can be cultivated for the production of useful physiologically active substances.
Abstract: Nonanchorage-dependent cells are immobilized for cell culturing or the production of cell products, by contracting an aqueous suspension of the cells with a floc formed by the combination of positively and negatively charged ion exchange resins having particle sizes ranging from about 0.01 to about 1.5 microns. The flocs may be formed either prior to contract with the cells or may be formed in situ in the cell suspension upon separate addition of the resins, preferably by first adding the positively charged resin followed by the negatively charged resin. The resin floc operates as a microcarrier for the cells.
Type:
Grant
Filed:
April 28, 1986
Date of Patent:
August 28, 1990
Assignee:
Rohm and Haas Company
Inventors:
Michael J. Byers, Eric G. Isacoff, John O. Naples
Abstract: 3',4'-anhydrovinblastine, a precursor of the anti-tumor alkaloids vincristine and vinblastine, is prepared by the enzymatic coupling of catharanthine and vindoline using an iron-containing compound such as peroxidase optionally in the presence of a peroxide. Substantially enhanced yields are obtained.
Type:
Grant
Filed:
August 4, 1986
Date of Patent:
April 17, 1990
Assignee:
Allelix Biopharmaceuticals Inc.
Inventors:
Anne E. Goodbody, Endo Tsuyoshi, John Vukovic, Masanaru Misawa